PTSD and Neurofeedback: New Therapeutic Pathways

Post-traumatic stress disorder (PTSD) is a complex and often treatment-resistant condition, especially prevalent among military personnel and veterans. Recent research into neurofeedback presents a new perspective, positioning this approach as a potential breakthrough in mental health care. This article builds on the reflections of Nicholson et al. and their pivotal 2020 study on neurofeedback for PTSD, which sheds light on new advances and ongoing research in this non-invasive therapeutic technique.

Methods

Neurofeedback works by training individuals to regulate their brain activity in real time. The 2020 study by Nicholson and colleagues explored the use of both EEG (electroencephalography) and fMRI (functional magnetic resonance imaging) neurofeedback to help individuals with PTSD manage their neural responses. The focus was on key brain regions associated with trauma, particularly the amygdala and the posterior cingulate cortex (PCC).

Traditionally, the amygdala—central to emotional and fear processing—has been a frequent neurofeedback target due to its heightened activation in PTSD. However, the PCC has more recently gained attention for its role in self-referential processing and trauma recall. A 2023 study comparing amygdala- and PCC-targeted neurofeedback sessions found that regulating the PCC may lead to more generalizable and widespread neural effects.

Results

Nicholson’s team observed clear differences between PCC- and amygdala-targeted neurofeedback. Participants in the PCC group reported reduced symptoms such as intrusive traumatic memories and showed decreased brain-wide neural activity, suggesting broader regulatory outcomes. In contrast, amygdala-focused neurofeedback did not produce these global changes.

A double-blind randomized controlled trial (RCT) involving 20 EEG-based neurofeedback sessions yielded significant improvements: over 60% of participants in the active treatment group no longer met the diagnostic criteria for PTSD. EEG data revealed normalization of disrupted brainwave patterns, including a rebound in alpha activity, a marker often associated with reduced hypervigilance—one of PTSD’s core symptoms.

Brendan’s Perspective

One of neurofeedback’s most compelling strengths lies in its direct targeting of brain function, bypassing some of the barriers of traditional exposure therapies. This is particularly beneficial for individuals who experience severe anxiety or dissociation during talk-based treatments. By offering a brain-focused and non-invasive route, neurofeedback supports the restoration of neural self-regulation and homeostasis.

When it comes to PTSD treatment, shifting the therapeutic focus from the amygdala to the PCC could be transformative. The PCC’s role in integrating traumatic experiences into one’s identity makes it uniquely relevant for addressing the deep cognitive and emotional disruptions associated with PTSD. Rather than simply reducing symptoms, this approach may help individuals achieve greater mental stability and narrative integration.

Ongoing studies, including new work by Nicholson’s team, are exploring optimal treatment durations and combined models with psychotherapy. In one innovative approach, researchers are piloting home-based virtual neurofeedback sessions to be used prior to group therapy — a model that could make advanced treatment more accessible and scalable.

The PCC’s Role in the DMN and PTSD

The posterior cingulate cortex (PCC) is a core hub within the Default Mode Network (DMN) — a system deeply involved in self-referential thinking, autobiographical memory, and emotional processing. In PTSD, the DMN is often dysregulated, manifesting as persistent rumination, intrusive thoughts, and a fragmented sense of self. This makes the PCC a promising and strategic target for neurofeedback interventions.

Unlike the amygdala, which primarily governs acute fear responses and hypervigilance, the PCC supports the integration of traumatic memories into the personal narrative. When dysregulated, this region can contribute to disjointed or negative self-concepts—hallmarks of PTSD. Recent research shows that PCC-focused neurofeedback may enhance connectivity within the DMN, helping individuals break free from cycles of negative self-referential thinking.

More Than One Network: The SN and CEN in PTSD

PTSD is not solely a disorder of the DMN. It results from complex network-level dysfunctions involving the Salience Network (SN) and the Central Executive Network (CEN) as well.

• The Salience Network (SN), anchored in the anterior insula and anterior cingulate cortex, is responsible for detecting and prioritizing emotionally relevant stimuli. In PTSD, the SN often becomes hyperactive, leading to exaggerated threat perception and difficulty filtering out trauma-related triggers. This persistent overactivation fuels hypervigilance and emotional dysregulation. Neurofeedback protocols targeting the SN have shown effectiveness in calming these overreactions and restoring emotional balance.

• The Central Executive Network (CEN), centered in the dorsolateral prefrontal cortex, oversees high-level cognitive functions like working memory, attention, and decision-making. PTSD can suppress CEN activity, contributing to impaired executive function, poor concentration, and a diminished ability to manage emotions triggered by the SN. Neurofeedback aimed at rebalancing SN and CEN activity helps patients regain cognitive control and diminish emotional overwhelm.

Crucially, the PCC serves as a bridge between these networks. A dysregulated DMN can disrupt the delicate balance between the SN and CEN, intensifying PTSD symptoms. For example, a hyperactive SN might repeatedly push trauma-related cues into consciousness, while a weakened CEN fails to redirect attention or suppress maladaptive responses. By improving PCC function through neurofeedback, we not only stabilize the DMN but also enhance coordination across all three networks — DMN, SN, and CEN — fostering more comprehensive symptom relief.

Rethinking PTSD Treatment

These insights clearly show that an amygdala-only focus is insufficient for treating PTSD. While fear extinction remains important, addressing whole-brain network dysfunctions in the DMN, SN, and CEN opens the door to a more holistic and integrated therapeutic strategy.

PCC-targeted neurofeedback stands out as a multi-dimensional intervention, capable of recalibrating the brain’s interconnected systems. It doesn’t just soothe trauma-related symptoms—it restores identity coherence, cognitive function, and emotional flexibility.

Conclusion

The emerging role of neurofeedback in PTSD treatment signals a paradigm shift toward brain-centered, personalized therapies. As research continues to evolve, understanding which brain targets deliver the most therapeutic benefit — and how to best integrate neurofeedback into broader mental health systems — becomes increasingly essential.

The pioneering work of Nicholson and colleagues continues to chart this new terrain, offering hope and renewed possibility for veterans, active service members, and all individuals navigating the lasting effects of trauma.

Reference

Nicholson, A. A., Ros, T., Jetly, R., Lanius, R. A., & Hosseiny, F. (2024). Reflection on JMVFH’s most popular article of 2020: Regulating PTSD symptoms with neurofeedback: Taking back the brain. Journal of Military, Veteran and Family Health, 10(4), 79–82. https://doi.org/10.3138/jmvfh-0718-0014